Related Experiment Videos
[Difluocortolone valerate: a new corticoid for topical use]
Zeitschrift Fur Hautkrankheiten
|January 1, 1976
Summary
Diflucortolone valerate fatty ointment showed excellent clinical efficacy for dry skin conditions like atopic eczema. This topical corticosteroid treatment was well-tolerated, with no adverse effects reported in patients.
Area of Science:
- Dermatology
- Clinical Pharmacology
Background:
- Very dry dermatoses represent a significant clinical challenge, often requiring effective topical treatments.
- Fatty ointments provide a protective barrier and enhance drug delivery for skin conditions.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of diflucortolone valerate in a fatty ointment formulation.
- To assess treatment outcomes in patients suffering from various forms of severe dry skin.
Main Methods:
- A clinical investigation was conducted on 65 patients diagnosed with very dry dermatoses.
- Diflucortolone valerate was administered as a fatty ointment.
- Patient outcomes and side effects were systematically monitored.
Main Results:
- The fatty ointment formulation of diflucortolone valerate demonstrated highly positive clinical efficacy.
- Excellent results were observed in patients with atopic eczema, neurodermatitis, and atopic cheilitis.
- No adverse side effects were reported during the study period.
Conclusions:
- Diflucortolone valerate in a fatty ointment is a safe and highly effective treatment for severe dry dermatoses.
- The formulation is particularly beneficial for inflammatory conditions such as atopic eczema, neurodermatitis, and atopic cheilitis.
- The absence of side effects supports its favorable safety profile for dermatological use.